MedTrace Logo

Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1

NCT00000315 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to determine the density of DA transporters during prolonged cocaine abuse and during withdrawal from cocaine use. This aim will test the hypothesis that DA transporters are altered by cocaine abuse and reestablished during withdrawal.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Cocaine

Sponsors & Collaborators

Principal Investigators

  • Dean Wong, M.D., Ph.D. · Johns Hopkins University

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-11-30
Completion
2001-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000315 on ClinicalTrials.gov